SCHEMBL21028343

SCHEMBL21028343

CCc1cc(C(=O)NC(C)(C)C)cc(C(C)(C)C)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.42
HTT P42858 1/20 0.42
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
HDAC3 O15379 2/20 0.40
HDAC6 Q9UBN7 2/20 0.40
CACNA1H O95180 1/20 0.38
HDAC8 Q9BY41 2/20 0.38
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HDAC4 P56524 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
HDAC9 Q9UKV0 1/20 0.37
HDAC5 Q9UQL6 1/20 0.37
ESRRG P62508 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17789598 0.88 MEN1 (0.44) LMNAHTTMEN1KMT2ACACNA1H
SCHEMBL19590653 0.88 NOTUM (0.44) LMNAHTTCACNA1HALDH1A1
SCHEMBL10233568 0.85 PLK1 (0.51) MEN1KMT2AHDAC3HDAC6HDAC8
SCHEMBL14228294 0.85 HDAC6 (0.55) MEN1KMT2AHDAC3HDAC6HDAC8
SCHEMBL19590713 0.85 KMT2A (0.39) LMNAHTTMEN1KMT2ACACNA1H
SCHEMBL14293711 0.80 NOTUM (0.49) LMNAALDH1A1
SCHEMBL10235447 0.80 RXRA (0.47) ALDH1A1
SCHEMBL10283834 0.79 LMNA (0.56) LMNAHTTMEN1KMT2AALDH1A1
SCHEMBL10233693 0.78 EPHX2 (0.43) LMNAHTTMEN1KMT2AHDAC8
SCHEMBL15726940 0.78 ANO1 (0.45) LMNAHTTMEN1KMT2AHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10301272-B2 Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ROR[γ] PHENEX PHARMACEUTICALS AG (DE) 2019-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10301272-B2 Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ROR[γ] RORA, RORB, RORC LMNA 4258/4885HTT 4429/4885MEN1 4461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.